About me

Research Assistant Professor of Radiology

Spoken languages

English

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Dr. Lee is a Penn Medicine provider.

Qualifications and experience

All conditions and treatments

Research

Publications

Scott PJH, Lee HS, VanBrocklin HF, Parr DC, Nazerias M, Mishoe A, Ignace C, Zigler SS. FDA Policy Changes on Stability Studies for PET Drugs Manufactured Within Networks , J Nucl Med: 2026

Sharma N, Sarkar S, Etersque JM, Edwards KJ, Pham JM, Xu K, Scheuermann J, Nguyen T, Ruff A, Martorano P, Northrup JD, Lohith K, Lee HS, Farwell MD, Pryma D, Sellmyer MA. Theranostic Approach Using Radioiodinated Trimethoprim Targeting E. coli Dihydrofolate Reductase in Engineered Cells , J Nucl Med, 67(10): 2026,1627-1634

Paul Martorano, Surendra Reddy Gundam, Siran Qian, Casey J. McCarthy, Shelbie Cingoranelli, Kevin Cheng, E. William Webb, Gregory D. Bowden, Hong Beom Lee, Paul Ellison, Peter J. H. Scott, Robert H. Mach, Mehran Makvandi, Hsiaoju S. Lee & Jay S. Wright Copper-mediated 77Br, 125I, and 211At radiohalogenation of aryl thianthrenium salts using visible light , NPJ Imaging: 2026

Linden HM, O'Brien SR, van de Ven SM, La Porte P, Conti PS, Peddi PF, Mortimer JE, Brenin C, Takalkar AM, McGuinness JE, Cheng E, Rao A, Peterson LM, Specht JM, Wong TZ, Buck DA, Brufsky AM, Ulaner GA. Clinical Utility of [(18)F]Fluoroestradiol PET/CT to Guide Second Line Treatment Decision in ER-Positive HER2-Negative Metastatic Breast Cancer After Progression on First Line Endocrine Therapy , Clin Breast Cancer, 26(11): 2026,32-39

Konstantinos Plakas, Bhasker Radaram, Banafshe Samani, Chia-Ju Hsieh, Anthony Young, Alexander Schmitz, Catherine Hou, Zachary Kelley, Jonathan Yu, Martin Rauch, Tolulope Aweda, Nicole C. Goodwin, Reid Groseclose, Amine Aziez, Hasan Alsaid, Robert H. Mach & Hsiaoju S. Lee Total-body PET of two approved PARP inhibitors: [18F]Olaparib and [11C]Niraparib in Non-Human Primates , EJNMMI radiopharm. chem.: 2026

Weng CC, Chu CH, Khan F, Li S, Lee H, Mach RH, Hsu CH, Chung YH. Evaluating the tumour detection efficacy of [(18)F]Fluorthanatrace positron emission tomography in a metastatic lung cancer animal model , Nucl Med Biol, 158-159: 2026,109642

Tian GL, Hsieh CJ, Saturnino Guarino D, Lengyel-Zhand Z, Chia WK, Li S, Graham TJA, Hou C, Lee H, Young AJ, Petersson EJ, Mach RH. A Structure-Activity Relationship Study of Alpha Synuclein PET Radiotracer M503-1619 , Molecules, 31: 2026,2513

Hwan Lee, Swarbhanu Sarkar, Kexiang Xu, Paul Martorano, Jonathan Pham, Peter Sang Uk Park, A Paden King, Hsiaoju S Lee, David A Mankoff, Daniel A Pryma, Mark A Sellmyer Influence of Subcellular Localization on the Cytotoxicity of Targeted α-Therapy , J Nucl Med, 67(3): 2026,429-437

Young AJ, Doot RK, Cho JK, Pham JM, Ordonez AA, Del Castillo AF, Dominguez TL, Dugyala S, Schubert EK, Lee H, Pantel AR, Mach RH, Mankoff DA, Sellmyer MA. First-in-Human Biodistribution and Dosimetry of [(11)C]Trimethoprim , Mol Imaging Biol, 28(1): 2026,60-67

Siran Qian, Surendra Reddy Gundam, Carol Garcia, Shihong Li, Hsiaoju Lee, Jay S Wright C-H (radio)fluorination of hydroxamides via strained and electronically tunable α-lactams enabled by N-O scission , Nucl Med Biol., 152-153: 2026,109594

Hsiaoju (Sharon) Lee, PhD